Table 3.
Variable | HbA1c | Cholesterol | CVD risk |
---|---|---|---|
NHANES | |||
Intercept | 4.882 [4.837; 4.927] | 4.962 [4.920; 5.005] | − 0.673 [− 0.709; − 0.637] |
Degree (ref. other qualification) | − 0.246 [− 0.291; − 0.201] | − 0.069 [− 0.112; − 0.027] | − 0.167 [− 0.196; − 0.138] |
No qualification | 0.210 [0.176; 0.245] | 0.107 [0.075; 0.140] | 0.101 [0.079; 0.124] |
Year | 0.018 [0.015; 0.020] | − 0.021 [− 0.023; − 0.019] | − 0.019 [− 0.021; − 0.017] |
Degree x Year | 0.003 [0.001; 0.006] | 0.003 [0.001; 0.006] | 0.002 [0.000; 0.003] |
No qualification x Year | − 0.001 [− 0.003; 0.001] | − 0.007 [− 0.009; − 0.006] | − 0.002 [− 0.003; − 0.001] |
n | 138012 | 136204 | 127492 |
m | 148 | 148 | 148 |
HSE | |||
Intercept | 3.824 [3.652; 3.995] | 5.073 [5.039; 5.107] | − 0.326 [− 0.351; − 0.301] |
Degree (ref. other qualification) | − 0.006 [− 0.045; 0.033] | − 0.011 [− 0.052; 0.029] | − 0.068 [− 0.103; − 0.033] |
No qualification | 0.054 [0.026; 0.082] | 0.281 [0.253; 0.310] | 0.285 [0.260; 0.309] |
Year | 0.047 [0.045; 0.049] | − 0.029 [− 0.031; − 0.028] | − 0.012 [− 0.013; − 0.010] |
Degree x Year | − 0.004 [− 0.006; − 0.002] | 0.000 [− 0.002; 0.002] | − 0.001 [− 0.003; 0.001] |
No qualification x Year | 0.005 [0.003; 0.006] | − 0.021 [− 0.023; − 0.019] | − 0.008 [− 0.010; − 0.007] |
n | 66071 | 88809 | 39469 |
m | 31 | 32 | 31 |
SHS | |||
Intercept | 4.257 [4.132; 4.381] | 4.666 [4.539; 4.792] | − 0.207 [− 0.343; − 0.072] |
Degree (ref. other qualification) | 0.210 [0.010; 0.411] | 0.018 [− 0.121; 0.158] | 0.171 [− 0.054; 0.397] |
No qualification | 0.244 [0.060; 0.429] | 0.110 [− 0.021; 0.241] | 0.283 [0.077; 0.489] |
Year | 0.059 [0.051; 0.066] | 0.002 [− 0.005; 0.010] | − 0.005 [− 0.013; 0.003] |
Degree x Year | − 0.017 [− 0.029; − 0.004] | − 0.000 [− 0.011; 0.011] | − 0.014 [− 0.028; 0.001] |
No qualification x Year | − 0.007 [− 0.020; 0.005] | − 0.006 [− 0.017; 0.005] | − 0.009 [− 0.023; 0.005] |
n | 7168 | 10781 | 3723 |
m | 21 | 21 | 21 |
Coefficients and 99% confidence intervals. m and n: number of random-effect strata levels and sample size, respectively. HbA1c glycated haemoglobin, CVD cardiovascular disease, Log logarithm